DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howell, S. R.
Right arrow Articles by Ulm, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howell, S. R.
Right arrow Articles by Ulm, E. H.

Vol. 26, Issue 3, 234-239, March 1998

Effects of Retinoid Treatment of Rats on Hepatic Microsomal Metabolism and Cytochromes P450
Correlation Between Retinoic Acid Receptor/Retinoid X Receptor Selectivity and Effects on Metabolic Enzymes

Stanley R. Howell, Michael A. Shirley, and Edgar H. Ulm

Department of Drug Safety and Disposition, Ligand Pharmaceuticals, Inc.

Retinoids are compounds that bind to and activate one or more retinoid receptors to elicit various physiological responses. There are two families of retinoid receptors, i.e. retinoic acid receptors (RAR) and retinoid X receptors (RXR), for which the various synthetic and naturally occurring retinoids have differing selectivities. The synthetic analogs LG100268 and LGD1069 (Targretin) are RXR-selective, whereas ALRT1550 is highly RAR-selective. Naturally occurring all-trans-retinoic acid (Tretinoin) has a degree of selectivity for RAR, whereas ALRT1057 (9-cis-retinoic acid, Panretin) is equally active at RAR and RXR (i.e. a pan-agonist). To evaluate the effects of these compounds on metabolic enzymes, male Sprague-Dawley rats received daily oral doses for 4 days, and liver microsomes were prepared on day 5. As a class, these ligands exerted profound effects on hepatic microsomal metabolic enzyme levels. Those with RAR activity decreased hepatic cytochrome P450 (CYP or P450) levels and in vitro metabolism of the compound of pretreatment, whereas those exerting predominantly RXR activity increased these parameters. A similar relationship was observed when glucuronidation was examined. Hepatic CYP2B1/2 was unaffected and CYP3A was decreased by RAR-selective ALRT1550, whereas both were induced by ligands selective for RXR. However, both RAR- and RXR-selective ligands decreased CYP1A2, whereas they induced CYP4A. Although the mechanisms underlying these effects are not known, these results suggest that RAR- and RXR-binding ligands exert distinct effects on hepatic metabolism, and they indicate the potential for drug-drug interactions, especially involving CYP3A. The nature of such interactions would depend on the RAR/RXR selectivity of the ligand and the P450 isozymes responsible for the metabolism of coadministered drugs.

Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
J. W. A. Smit, M. P. M. Stokkel, A. M. Pereira, J. A. Romijn, and T. J. Visser
Bexarotene-Induced Hypothyroidism: Bexarotene Stimulates the Peripheral Metabolism of Thyroid Hormones
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2496 - 2499.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. M. Golden, K. B. Weber, T. L. Hernandez, S. I. Sherman, W. W. Woodmansee, and B. R. Haugen
Single-Dose Rexinoid Rapidly and Specifically Suppresses Serum Thyrotropin in Normal Subjects
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 124 - 130.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
K. Wang, A. J. Mendy, G. Dai, H.-R. Luo, L. He, and Y.-J. Y. Wan
Retinoids Activate the RXR/SXR-Mediated Pathway and Induce the Endogenous CYP3A4 Activity in Huh7 Human Hepatoma Cells
Toxicol. Sci., July 1, 2006; 92(1): 51 - 60.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. F. Sah, R. L. Eckert, R. A. S. Chandraratna, and E. A. Rorke
Retinoids Suppress Epidermal Growth Factor-associated Cell Proliferation by Inhibiting Epidermal Growth Factor Receptor-dependent ERK1/2 Activation
J. Biol. Chem., March 15, 2002; 277(12): 9728 - 9735.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
A. Lampen, S. Meyer, and H. Nau
Effects of Receptor-Selective Retinoids on CYP26 Gene Expression and Metabolism of All-trans-Retinoic Acid in Intestinal Cells
Drug Metab. Dispos., April 13, 2001; 29(5): 742 - 747.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
D. Deplewski and R. L. Rosenfield
Role of Hormones in Pilosebaceous Unit Development
Endocr. Rev., August 1, 2000; 21(4): 363 - 392.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. L. McCormick, K. V. N. Rao, V. E. Steele, R. A. Lubet, G. J. Kelloff, and M. C. Bosland
Chemoprevention of Rat Prostate Carcinogenesis by 9-cis-Retinoic Acid
Cancer Res., February 1, 1999; 59(3): 521 - 524.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. Xie and R. M. Evans
Orphan Nuclear Receptors: The Exotics of Xenobiotics
J. Biol. Chem., October 5, 2001; 276(41): 37739 - 37742.
[Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.